English
  1. Home
  2. Stocks
  3. Concord Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Concord Drugs Share Price Concord Drugs

    Small Cap
    ₹36.48
    +0.48 (1.33%)
    13 May, 2024 21:19 BSE: 538965 NSE: CONCORDISIN: INE858L01010

    Start SIP in Concord Drugs

    Start SIP

    Concord Drugs Performance

    Day Range

    • Low 0
    • High 0
    ₹ 36

    52 Week Range

    • Low 0
    • High 0
    ₹ 36
    • Open Price0
    • Previous Close0
    • Volume

    Concord Drugs Share Price

    • Over 1 Month -2.95%
    • Over 3 Month -19.01%
    • Over 6 Month +6.64%
    • Over 1 Year +23.66%

    Concord Drugs Key Statistics

    Concord Drugs Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 137912
    Operating Expenses Qtr Cr 126711
    Operating Profit Qtr Cr 1211
    Depreciation Qtr Cr 0000
    Interest Qtr Cr 0000
    Tax Qtr Cr 0000
    Net Profit Qtr Cr 0100
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 51
    Operating Expenses Annual Cr 47
    Operating Profit Annual in Cr 4
    Depreciation Cr 2
    Interest Annual Cr 2
    Tax Annual Cr 0
    Net Profit Annual Cr 1
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 2
    Cash from Investing Activity Annual Cr -2
    Cash from Financing Annual Activity Cr 0
    Net Cash Flow Annual Cr 0
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 32
    Fixed Assets Annual Cr 14
    Total Non Current Assets Annual Cr 15
    Total Current Assets Annual Cr 41
    Total Assets Annual Cr 57
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 34
    ROE Annual % 3
    ROCE Annual % 8
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 8
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1389
    Operating Expenses Qtr Cr 1268
    Operating Profit Qtr Cr 121
    Depreciation Qtr Cr 000
    Interest Qtr Cr 000
    Tax Qtr Cr 000
    Net Profit Qtr Cr 010
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Concord Drugs

    Concord Drugs Technicals

    EMA & SMA

    Current Price
    ₹36.48
    +0.48 (1.33%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹36.65
    • 50 Day
    • ₹37.65
    • 100 Day
    • ₹38.37
    • 200 Day
    • ₹37.34
    • 20 Day
    • ₹36.69
    • 50 Day
    • ₹37.14
    • 100 Day
    • ₹41.16
    • 200 Day
    • ₹37.91

    Concord Drugs Resistance and Support

    PIVOT
    ₹35.85
    Resistance
    First Resistance 37.37
    Second Resistance 38.27
    Third Resistance 39.79
    RSI 47.14
    MFI 37.89
    MACD Single Line -0.32
    MACD -0.37
    Support
    First Resistance 34.95
    Second Resistance 33.43
    Third Resistance 32.53

    Concord Drugs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,178 101,296 85.99
    Week 3,919 352,903 90.04
    1 Month 6,030 484,717 80.38
    6 Month 25,211 1,787,213 70.89

    Concord Drugs Result Highlights

    Concord Drugs Synopsis

    NSE-Medical-Biomed/Biotech

    Concord Biotech Ltd. is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 853.17 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2023. Concord Biotech Ltd. is a Public Limited Listed company incorporated on 23/11/1984 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24230GJ1984PLC007440 and registration number is 007440.
    Market Cap 15,948
    Sales 971
    Shares in Float 5.86
    No of funds 91
    Yield
    Book Value 12.22
    U/D Vol ratio 2.1
    LTDebt / Equity 3
    Alpha 0.29
    Beta 0.59

    Concord Drugs

    Owner NameMar-24Dec-23Sep-23
    Promoters 44.08%44.08%44.08%
    Mutual Funds 5.15%5.65%5.58%
    Insurance Companies 2.88%2.47%2.26%
    Foreign Portfolio Investors 6.49%7%7.3%
    Individual Investors 7.08%6.76%6.78%
    Others 34.32%34.04%34%

    Concord Drugs Management

    Name Designation
    Mr. Sudhir Vaid Chairman & Managing Director
    Mr. Ankur Vaid Joint Managing Director & CEO
    Mr. Ravi Kapoor Non Executive Director
    Mr. Rajiv Ambrish Agarwal Non Exe. & Nominee Director
    Mr. Utpal Sheth Non Exe. & Nominee Director
    Mr. Amit Varma Non Exe. & Nominee Director
    Ms. Bharti Khanna Independent Director
    Mr. Anil Katyal Independent Director
    Mr. Amitabh Thakore Independent Director
    Mr. Arvind Agarwal Independent Director
    Mr. Jayaram Easwaran Independent Director
    Mr. Mandayam Chakravarthy Sriraman Independent Director

    Concord Drugs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Concord Drugs Corporate Action

    Date Purpose Remarks
    2024-02-13 Quarterly Results
    2023-11-14 Quarterly Results
    2023-08-14 Quarterly Results
    2023-05-30 Audited Results
    2023-02-14 Quarterly Results

    Concord Drugs MF Shareholding

    Name Amount(cr)

    Concord Drugs FAQs

    What is Share Price of Concord Drugs ?

    Concord Drugs share price is ₹36 As on 13 May, 2024 | 21:05

    What is the Market Cap of Concord Drugs ?

    The Market Cap of Concord Drugs is ₹34 Cr As on 13 May, 2024 | 21:05

    What is the P/E ratio of Concord Drugs ?

    The P/E ratio of Concord Drugs is 40.3 As on 13 May, 2024 | 21:05

    What is the PB ratio of Concord Drugs ?

    The PB ratio of Concord Drugs is 1.1 As on 13 May, 2024 | 21:05

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.